Literature DB >> 20819260

Serum 25-hydroxy-vitamin D3 concentrations increase during tuberculosis treatment in Tanzania.

A Tostmann1, J P M Wielders, G S Kibiki, H Verhoef, M J Boeree, A J A M van der Ven.   

Abstract

SETTING: Vitamin D deficiency is associated with susceptibility to active tuberculosis (TB) in many settings. In vitro studies and studies on human volunteers showed that two of the first-line anti-tuberculosis drugs, isoniazid and rifampicin, reduce 25-hydroxy vitamin D (25[OH]D) concentrations.
OBJECTIVE: To study changes in vitamin D status during treatment of Tanzanian hospitalised patients with pulmonary TB (PTB).
DESIGN: We compared serum 25[OH]D concentrations in 81 Tanzanian PTB patients before and after 2 months of treatment.
RESULTS: Median serum 25[OH]D concentrations increased from 91 nmol/l at baseline to 101 nmol/l after 2 months of TB treatment (median increase 6.0 nmol/l, IQR -0.7-25.0, P = 0.001). Median serum parathyroid hormone concentrations increased from 1.6 to 2.0 pmol/l (median increase 0.46, IQR -0.2-1.1, P < 0.001).
CONCLUSION: 25[OH]D serum concentrations increased during the first 2 months of TB treatment in 81 PTB patients in northern Tanzania. Improved dietary intake and increased sunlight exposure may have contributed to the increased 25[OH]D concentrations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20819260

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  15 in total

1.  Relationship of vitamin D insufficiency to AIDS-associated Kaposi's sarcoma outcomes: retrospective analysis of a prospective clinical trial in Zimbabwe.

Authors:  Kristine M Erlandson; Ivy Gudza; Suzanne Fiorillo; Buxton Ndemera; Robert T Schooley; Lovemore Gwanzura; Margaret Borok; Thomas B Campbell
Journal:  Int J Infect Dis       Date:  2014-04-21       Impact factor: 3.623

2.  Effect of DOTS Treatment on Vitamin D Levels in Pulmonary Tuberculosis.

Authors:  Akshatha Lalesh Naik; Madan Gopal Rajan; Poornima A Manjrekar; Mamatha T Shenoy; Souparnika Shreelata; Rukmini Mysore Srikantiah; Anupama Hegde
Journal:  J Clin Diagn Res       Date:  2017-04-01

3.  Daily adjunctive therapy with vitamin D3 and phenylbutyrate supports clinical recovery from pulmonary tuberculosis: a randomized controlled trial in Ethiopia.

Authors:  A Bekele; N Gebreselassie; S Ashenafi; E Kassa; G Aseffa; W Amogne; M Getachew; A Aseffa; A Worku; R Raqib; B Agerberth; U Hammar; P Bergman; G Aderaye; J Andersson; S Brighenti
Journal:  J Intern Med       Date:  2018-05-23       Impact factor: 8.989

4.  Levels of 1,25(OH)2D3 for patients with pulmonary tuberculosis and correlations of 1,25(OH)2D3 with the clinical features of TB.

Authors:  Wei-Wei Gao; Yu Wang; Xiang-Rong Zhang; Chun-Yang Yin; Chun-Mei Hu; Man Tian; Hong-Wei Wang; Xia Zhang
Journal:  J Thorac Dis       Date:  2014-06       Impact factor: 2.895

Review 5.  Vitamin D and influenza.

Authors:  Maria E Sundaram; Laura A Coleman
Journal:  Adv Nutr       Date:  2012-07-01       Impact factor: 8.701

6.  Reciprocal seasonal variation in vitamin D status and tuberculosis notifications in Cape Town, South Africa.

Authors:  Adrian R Martineau; Shepherd Nhamoyebonde; Tolu Oni; Molebogeng X Rangaka; Suzaan Marais; Nonzwakazi Bangani; Relebohile Tsekela; Lizl Bashe; Virginia de Azevedo; Judy Caldwell; Timothy R Venton; Peter M Timms; Katalin A Wilkinson; Robert J Wilkinson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-24       Impact factor: 11.205

7.  Vitamin D deficiency in Malawian adults with pulmonary tuberculosis: risk factors and treatment outcomes.

Authors:  D J Sloan; H C Mwandumba; M Kamdolozi; D Shani; B Chisale; J Dutton; S H Khoo; T J Allain; G R Davies
Journal:  Int J Tuberc Lung Dis       Date:  2015-08       Impact factor: 2.373

8.  Serum Vitamin D Level as a Risk Factor for Female Genital Tuberculosis (FGTB).

Authors:  Swati Gautam; Amita Jain; Salman Akhtar; Apala Priyadarshini; Shyam Pyari Jaiswar
Journal:  J Clin Diagn Res       Date:  2017-09-01

9.  L-arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trial.

Authors:  Anna P Ralph; Govert Waramori; Gysje J Pontororing; Enny Kenangalem; Andri Wiguna; Emiliana Tjitra; Dina B Lolong; Tsin W Yeo; Mark D Chatfield; Retno K Soemanto; Ivan Bastian; Richard Lumb; Graeme P Maguire; John Eisman; Ric N Price; Peter S Morris; Paul M Kelly; Nicholas M Anstey
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

10.  Vitamin D and tuberculosis: a multicenter study in children.

Authors:  Elisabetta Venturini; Ludovica Facchini; Nuria Martinez-Alier; Vas Novelli; Luisa Galli; Maurizio de Martino; Elena Chiappini
Journal:  BMC Infect Dis       Date:  2014-12-11       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.